Anavex Life Sciences logo
Anavex Life Sciences
AVXL | NASDAQ
Chart Builder DCF Calculator
$0.82
-$0.11 (-12.16%)
At close: Nov 16, 2026, 4:00 PM ET
$0.85
+$0.03 (+3.66%)
After-hours: Nov 16, 2026, 7:30 PM ET

Anavex Life Sciences Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Sep 30, 2025
FY 2024
Sep 30, 2024
FY 2023
Sep 30, 2023
FY 2022
Sep 30, 2022
FY 2021
Sep 30, 2021
FY 2020
Sep 30, 2020
-46.38M -43M -47.51M -47.98M -37.91M -26.28M
– – – – – –
11.55M 9.44M 16.37M 18.38M 8.23M 4.88M
-478K -2.81M 1.52M 331K 2.83M 1.86M
– – 845K – – –
– – – – – –
-4.22M 2.75M 2.51M 5.36M -706K 116.52K
-39.04M -30.81M -27.79M -24.24M -30.38M -21.29M
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –
– – – – – –
-2.71M – – -707K 24K -403.76K
9.43M 11.98M 29.65M 21.29M 153.24M 28.35M
-29.61M -18.84M 1.87M -2.95M 122.86M 7.06M
-39.04M -30.81M -27.79M -24.24M -30.38M -21.29M
-50.59M -40.25M -44.16M -42.62M -38.62M -26.16M
– – – – – –
– – – – – –
-39.04M -30.81M -27.79M -24.24M -30.38M -21.29M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.